Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115280) titled 'The use of colorectal cancer organoids to study the clonal origin and the molecular mechanism of drug-tolerant persister cells underlying resistance to irinotecan' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Shenzhen Second People's Hospital
Condition:
Colorectal cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Trial group:20;
Countries of Recruitment:
Chine
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300630
Published by HT Digital Content Services with permission ...